Moderna weighs private market debut for COVID shot as federal funding flounders
March 25, 2022How to accelerate reliable and novel answers with expert-curated biomedical and clinical data
March 28, 2022The companies said the FDA is now requiring results from a randomized study in the latest sign the agency is raising the bar for accelerated approval of so-called PI3K inhibitors.
